This Perspective describes the blueprint, challenges and potential solutions for the transformation of Alzheimer’s disease clinical care pathway with biomarker-guided and digitally facilitated detection and intervention at early disease stages.
- Harald Hampel
- Rhoda Au
- Jeffrey Cummings
